Bengaluru-based life sciences startup Biodimension has raised Rs 8 crore in a funding round led by IAN Angel Fund. Existing investor Campus Angels Network, Dr. Sampath Srisailam, and angel investor Aaryan Baid also participated in the round. The proceeds will be used to accelerate product development, expand laboratory infrastructure, strengthen scientific and commercial teams, and support the commercialization of its products in India and overseas markets. Founded by Manojkumar S., Ranjith Kumar Velusamy, and Pradeep Arunachalam, Biodimension develops biofabricated human tissue and organoid models as alternatives to animal testing for pharmaceutical, biotechnology, and cosmetic companies. The startup's portfolio includes BioDEpi, BioDFT, BioDPigma, a Pan-Cancer Tumour Microenvironment (TME) Biobank, and Bioassay-as-a-Service (BaaS), which provide human-relevant testing solutions for research, safety assessment, and drug discovery. Biodimension said it has established collaborations with pharmaceutical firms, biotech companies, research institutions, and contract research organizations across India and Singapore. The company plans to expand its oncology research offerings, scale its Bioassay-as-a-Service platform, and enter additional international markets, including Southeast Asia. Bareback Media has recently raised funding from a group of investors. Some of the investors may directly or indirectly be involved in a competing business or might be associated with other companies we might write about. This shall, however, not influence our reporting or coverage in any manner whatsoever. You may find a list of our investorshere.
